Main Article Content
The article deals with the problem of gastrointestinal complications during administration of nonsteroidal anti-inflammatory drugs, commonly used to treat a range of conditions, particularly rheumatic diseases. The results of own researches, which served to define the characteristics of changes in the state of gastric secretory function in patients receiving non-selective and selective anti-inflammatory agent and their comparative analysis, are provided. The data obtained demonstrated a certain contribution to the understanding of the mechanism of development of complications from the gastrointestinal tract when taken drugs of above group.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.
Gupta S. Management of Nonsteroidal, Anti-inflammatory, Drug-Associated Dyspepsia / S. Gupta, K. McQuaid // Gastroenterology. — 2005. — Vol. 129, Issue 5. — P. 1711-1719.
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia (the Canadian Adult Dyspepsia Empiric Treatment — Prompt Endoscopy (CADET-PE) study) / A.B. Thomson, A.N. Barkun, D. Armstrong [et al.] // Aliment. Pharmacol. Ther. — 2003. — № 17. — P. 1481-1491
Etiological factors of duodenal and gastric ulcers / A. Uyanikoğlu, A. Danalioğlu, F. Akyüz [et al.] // Turk. J. Gastroenterol. — 2012 Apr. — 23 (2). — P. 99-103.
Bjarnason I. Gastrointestinal safety of NSAIDs and over-the-counter analgesics / I. Bjarnason // Int. J. Clin. Pract. Suppl. — 2013 Jan. — 178. — P. 37-42.
Wallace J.L. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? / J.L. Wallace // Physiol. Rev. — 2008. — № 88 (4). — P. 1547-1565.
Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346) / J.L. Wallace, G. Caliendo, V. Santagada [et al.] // Br. J. Pharmacol. — 2010. — № 159 (6). — P. 1236-1246.
Determinants of the short-term gastric damage caused by NSAIDs in man / I. Bjarnason, C. Scarpignato, K. Takeuchi [et al.] // Alimentary Pharmacology & Therapeutics. — 2007. — Vol. 26, Issue 1. — P. 95-106.
Managing the Adverse Effects of Nonsteroidal Anti-inflammatory Drugs / P. Patrignani, S. Tacconelli, A. Bruno [et al.]// Expert Rev. Clin. Pharmacol. — 2011. — № 4 (5). — P. 605-621.
Aantiinflammatory drug (NSAID) induced mucosal injuries in stomach and small intestine / H. Matsui, O. Shimokawa, T. Kaneko [et al.] // J. Clin. Biochem. Nutr. — 2011. — Vol. 48, № 2. — P. 107-111.
Present status and strategy of NSAIDs-induced small bowel injury / K. Higuchi, E. Umegaki, T. Watanabe [et al.] // J. Gastroenterol. — 2009. — № 44 (9). — P. 879-888.
Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study / L. Maiden, B. Thjodleifsson, A. Seigal [et al.] // Clin Gastroenterol Hepatol. — 2007 Sep. — 5 (9). — P. 1040-1045.
Lim Y.J. Non-Steroidal Anti-Inflammatory Drug-Induced Enteropathy / Y.J. Lim, Ch.-H. Yang // Clin. Endosc. — 2012 June. — 45 (2). — P. 138-144.
Reuter B.K. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation / B.K. Reuter, N.M. Davies, J.L. Wallace // Gastroenterology. — 1997 Jan. — 112 (1). — P. 109-117.
Nylander O. The impact of cyclooxygenase inhibition on duodenal motility and mucosal alkaline secretion in anaesthetized rats / O. Nylander // Acta Physiol. (Oxf.). — 2011. — № 201 (1). — P. 179-192.
Satoh H. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility / H. Satoh, K. Amagase, K. Takeuchi // J. Pharmacol. Exp. Ther. — 2012 Nov. — 343 (2). — P. 270-277.
Jarupongprapa S. Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis / S. Jarupongprapa, P. Ussavasodhi, W. Katchamart // J. Gastroenterol. — 2012. — Dec 4. — Режим доступу до джерела: http://link.springer.com/article/10.1007%2Fs00535-012-0717-6.
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study / F.E. Silverstein, G. Faich, J.L. Goldstein [et al.] // JAMA. — 2000 Sep 13. — 284 (10). — P. 1247-1255.
The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs / van der Linden M.W., van der Bij S., Welsing P. [et al.] // Ann. Rheum. Dis. — 2009 May. — 68 (5). — P. 668-673.
Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis / T. Turajane, R. Wongbunnak, T. Patcharatrakul [et al.] // J. Med. Assoc. Thai. — 2009 Dec. — 92. — Suppl. 6. — P. S19-26.
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial / F.K. Chan, A. Lanas, J. Scheiman [et al.] // Lancet. — 2010 Jul 17. — 376 (9736). — P. 173-179.